Max Rosett - May 16, 2024 Form 4 Insider Report for Immunome Inc. (IMNM)

Role
EVP, Operations & CFO
Signature
/s/ Sandra Stoneman, Attorney-in-Fact
Stock symbol
IMNM
Transactions as of
May 16, 2024
Transactions value $
$0
Form type
4
Date filed
5/17/2024, 05:11 PM
Previous filing
Jan 31, 2024
Next filing
Aug 13, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IMNM Stock option (right to buy) Award $0 +30K $0.00 30K May 16, 2024 Common Stock 30K $14.40 Direct F1

Explanation of Responses:

Id Content
F1 25% of the shares subject to the options vest on May 16, 2025, and one-thirty-sixth (1/36th) of the remaining shares subject to the options shall vest every month thereafter.